НовостиBenzingaB. Riley Securities Maintains Buy on Veradermics, Raises Price Target to $204 B. Riley Securities Maintains Buy on Veradermics, Raises Price Target to $204 Benzinga 2026.10.22 17:00 (GMT+0) Открыть на Benzinga Другие новости